Abstract:Two polypyridyl ruthenium(II) complexes [Ru(DIP)2(BIP)](PF6)2 (DIP = 4,7-diphenyl-1,10-phenanthrolie, BIP = 2-(1,1'-biphenyl-4-yl)-1H-imidazo[4,5-f][1,10]phenanthroline, Ru1) and [Ru(DIP)2(CBIP)](PF6)2 (CBIP = 2-(4'-chloro-1,1'-biphenyl-4-yl)-1H-imidazo[4,5-f][1,10]phenanthroline, Ru2) were synthesized. The cytotoxic activities in vitro of Ru1, Ru2 toward B16, A549, HepG2, SGC-7901, HeLa, BEL-7402, non-cancer LO2 were investigated using MTT method (3-(4,5-dimethylthiazole)-2,5-diphenltetraazolium bromide). Unexpectedly, Ru1, Ru2 can't prevent these cancer cells proliferation. To improve the anti-cancer effect, we used liposomes to entrap the complexes Ru1, Ru2 to form Ru1lipo, Ru2lipo. As expectation, Ru1lipo and Ru2lipo exhibit high anti-cancer efficacy, especially, Ru1lipo (IC50 3.4 ± 0.1 μM), Ru2lipo (IC50 3.5 ± 0.1 μM) display strong ability to block the cell proliferation in SGC-7901. The cell colony, wound healing, and cell cycle distribution show that the complexes can validly inhibit the cell growth at G2/M phase. Apoptotic studied with Annex V/PI doubling method showed that Ru1lipo and Ru2lipo can effectively induce apoptosis. Reactive oxygen species (ROS), malondialdehyde, glutathione and GPX4 demonstrate that Ru1lipo and Ru2lipo improve ROS and malondialdehyde levels, inhibit generation of glutathione, and finally result in a ferroptosis. Ru1lipo and Ru2lipo interact on the lysosomes and mitochondria and damage mitochondrial dysfunction. Additionally, Ru1lipo and Ru2lipo increase intracellular Ca2+ concentration and induce autophagy. The RNA-sequence and molecular docking were performed, the expression of Bcl-2 family was investigated by Western blot analysis. Antitumor in vivo experiments confirm that 1.23 mg/kg, 2.46 mg/kg of Ru1lipo possesses a high inhibitory rate of 53.53% and 72.90% to prevent tumor growth, hematoxylin-eosin (H&E) results show that Ru1lipo doesn't cause chronic organ damage and strongly promotes the necrosis of solid tumor. Taken together, we conclude that Ru1lipo and Ru2lipo cause cell death through the following pathways: autophagy, ferroptosis, ROS-regulated mitochondrial dysfunction, and blocking the PI3K/AKT/mTOR.

Significant enhancement of anticancer effect of iridium (III) complexes encapsulated in liposomes

Enhanced in Vitro Cytotoxicity and Antitumor Activity in Vivo of Iridium(iii) Complexes Liposomes Targeting Endoplasmic Reticulum and Mitochondria

Studies of anticancer activity in vivo and in vitro behaviors of liposomes encapsulated iridium(III) complex

Targeted Liposomes Encapsulated Iridium(iii) Compound Greatly Enhance Anticancer Efficacy and Induce Cell Death Via Ferroptosis on HepG2 Cells

Increasing Anticancer Effect in Vitro and Vivo of Liposome-Encapsulated Iridium(iii) Complexes on BEL-7402 Cells.

Liposome as drug delivery system enhance anticancer activity of iridium (III) complex

Antitumor activity studies of iridium (III) polypyridine complexes-loaded liposomes against gastric tumor cell in vitro

Iridium(III) Complexes Entrapped in Liposomes Trigger Mitochondria-Mediated Apoptosis and GSDME-mediated Pyroptosis

Mitochondria-targeted iridium(III) complexes encapsulated in liposome induce cell death through ferroptosis and gasdermin-mediated pyroptosis

Anticancer effect evaluation in vitro and in vivo of iridium(III) polypyridyl complexes targeting DNA and mitochondria

White light increases anticancer effectiveness of iridium(III) complexes toward lung cancer A549 cells

Anticancer effect evaluation of iridium(III) complexes targeting mitochondria and endoplasmic reticulum.

DNA binding and evaluation of anticancer activity in vitro and in vivo of iridium(III) polypyridyl complexes

Novel half-sandwich iridium(iii) imino-pyridyl complexes showing remarkable in vitro anticancer activity.

Evaluation of anticancer effects in vitro of new iridium(III) complexes targeting the mitochondria

Novel Lysosome-Targeted Cyclometalated Iridium(III) Anticancer Complexes Containing Imine-N-heterocyclic Carbene Ligands: Synthesis, Spectroscopic Properties and Biological Activity

Evaluation of Efficiency of Liposome-Entrapped Iridium(III) Complexes Inhibiting Tumor Growth In Vitro and In Vivo

Induction of apoptosis in SGC-7901 cells by iridium(III) complexes via endoplasmic reticulum stress-mitochondrial dysfunction pathway

Synthesis, Characterization and Anticancer Efficacy Studies of Iridium (III) Polypyridyl Complexes against Colon Cancer HCT116 Cells

Iridium(III)-BBIP Complexes Induce Apoptosis Via PI3K/AKT/mTOR Pathway and Inhibit A549 Lung Tumor Growth in Vivo.

Significant increase of anticancer efficacy in vitro and in vivo of liposome entrapped ruthenium(II) polypyridyl complexes